• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Scientists Invent System to Improve Effectiveness of Cancer Surgery

Bioengineer by Bioengineer
January 21, 2015
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

With the goal of making it easier for surgeons to detect malignant tissue during surgery and hopefully reduce the rate of cancer recurrence, scientists have invented a new imaging system that causes tumors to “light up” when a hand-held laser is directed at them.

wake forest

“A surgeon’s goal during cancer surgery is to remove the tumor, as well as enough surrounding tissue to ensure that malignant cells are not left behind,” said Aaron Mohs, Ph.D., assistant professor of regenerative medicine at Wake Forest Baptist Medical Center and a co-inventor of the system. “But how do they know when they’ve removed enough tissue? Our goal is to provide better real-time information to guide the surgery.”

Published online ahead of print in IEEE Transactions on Biomedical Engineering (TBME), Mohs and co-authors report on their prototype system that combines a fluorescent dye that localizes in tumors with a real-time imaging system that allows the surgeon to simply view a screen to distinguish between normal tissue and the “lighted” malignant tissue.

In both mice and companion dogs with tumors, the scientists found that the fluorescent dye accumulated at higher levels in tumors than in the surrounding tissue and the system was able to detect a distinct boundary between normal and tumor tissue. Canine tumors are known to be similar to human tumors in architecture and canines get the same types of tumors as humans.

The scientists are working to further develop the system so it can be evaluated in human patients.
Current technology allows cancer surgeons to scan tumors prior to surgery with magnetic resonance imaging and other systems. However, to scan the tumor during surgery involves moving the patient from the operating table and into the machinery –which prolongs the surgery.

“Being able to quickly scan a tumor during surgery to visualize tumor tissue from non-tumor tissue is an unmet clinical need,” said Mohs. “Pathology techniques that examine tumor tissue during surgery can take up to 20 minutes and they focus on the tissue removed during surgery, not the tissue that remains in the body.”

In TBME, the authors noted that the ideal system would find tumor boundaries with high sensitivity, have minimal impact on operative time and surgical technique, present findings in an intuitive manner and avoid the use of ionizing radiation or a specialized imaging environment, such as MRI machines.
The system, invented by Mohs, Michael C. Mancini at Spectropath Inc., and Shuming Nie with Emory University and Georgia Institute of Technology, combines two types of imaging. A surgeon-controlled laser can be directed at any area of interest. In addition, an imaging system with three cameras sits above the surgical field. The images recorded by both systems are processed to display a composite image.

Using this system, a surgeon would scan the tumor prior to surgery to determine its boundaries. The tumor would then be surgically removed and the area would be re-scanned to assess for any remaining malignant tissue. If diseased tissue is found, it would be removed, and the process would be repeated until diseased tissue could no longer be detected.

In the prototype system reported in TBME, the scientists used indocyanine green dye as the source of fluorescence. They noted that future studies will focus on higher performance fluorescent dyes and nanoparticles that can be targeted to specific tumors.

Recently, Mohs was awarded a $1.37 million research grant from the National Institute of Biomedical Imaging and Bioengineering for a project to optimize the system and to test it in rodents.
Under the four-year project, Mohs’ team will develop nanoparticles based on hyaluronic acid, a substance naturally present in the human body. These nanoparticles will have the ability to entrap near infrared fluorescent dyes. The research will investigate invasive ductal carcinoma, the most common type of breast cancer.

Under the project, the researchers will focus on optimizing the loading of the dye, determining how fluorescence can be activated and performing studies in rodents to evaluate safety and whether disease recurrence is reduced.

Story Source:

The above story is based on materials provided by ake Forest Baptist Medical Center.

Share14Tweet9Share2ShareShareShare2

Related Posts

New Alliance Launches Clinical Trials of Targeted Therapies for Rare Adrenal Cancers

October 23, 2025

Illuminating Life: Rice Scientists Create Glowing Sensors to Monitor Cellular Changes in Real Time

October 23, 2025

Study Reveals Hidden Immune Defense Mechanism That Could Combat Cancer

October 23, 2025

Mayo Clinic Partners in Groundbreaking Study Demonstrating Enhanced Survival Rates for Early Breast Cancer Patients

October 23, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1277 shares
    Share 510 Tweet 319
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    308 shares
    Share 123 Tweet 77
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    167 shares
    Share 67 Tweet 42
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    132 shares
    Share 53 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Auditory Change Processing Markers Unusual in Autism

Innovative Center Pioneers Brighter Future for Trauma Survivors

Exploring Vicarious Trauma in Hospice Nurses

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 66 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.